Validation of the sentinel lymph node technique in cervical cancer at the Women’s Hospital

Authors

DOI:

https://doi.org/10.29193/RMU.40.2.8

Keywords:

CERVIX, CERVICAL CÁNCER, SENTINEL LYMPH NODE, VALIDATION STUDY, VALIDATION OF DIAGNOSTIC TECHNIQUE

Abstract

Introduction: Cervical cancer (CC) is a public health problem.  In Uruguay, it ranks third in incidence in women, causing 133 deaths annually. Lymph node involvement is one of its main prognostic factors and determines treatment. The sentinel lymph node (SLN) in early stages of cervical cancer is a safe technique that allows for adequate staging and reduces morbidity associated with conventional lymphadenectomy.
Objective: To validate the use of the SLN biopsy technique in early stages of CC as the standard treatment for detecting lymph node metastases at the Women’s Hospital.
Method: A prospective, longitudinal case study was conducted. Thirty patients with early-stage cervical cancer between January 2018 and November 2022 were included in the study. The marking was done with Tc99.  Systematic pelvic lymphadenectomy was performed in the same surgical procedure.
Results: Sentinel lymph nodes were detected bilaterally in 29 out of 30 patients. With a detection rate per region of 98.3%, metastatic SLNs were detected in 5 patients, with no positive non-sentinel nodes found. One of them corresponded to a micrometastasis detected by ultra-staging. Sensitivity was 100% (95% CI 56.55,100) with a negative predictive value of 100% (95% CI 86.68, 100).
Conclusions: According to the results of the study, the interdisciplinary team at the Women’s Hospital is in a position to use cervical SLN biopsy as the standard treatment for early-stage cervical cancer.

References

The International Agency for Research on Cancer. Global cancer observatory. Disponible en: https://gco.iarc.fr/ (Consulta: 4 julio 2023).

Comisión Honoraria de Lucha contra el Cáncer. Situación epidemiológica del Uruguay en relación al cancer. CHLCC, mayo 2002. Disponible en: https://www.comisioncancer.org.uy/Ocultas/SITUACION-EPIDEMIOLOGICA-DEL-URUGUAY-EN-RELACION-AL-CANCER-uc311. (Consulta: 2 julio 2023).

Bhatla N, Berek JS, Cuello Fredes M, Denny LA, Grenman S, Karunaratne K, et al. Revised FIGO staging for carcinoma of the cervix uteri. Int J Gynaecol Obstet 2019;145(1):129-35. doi: 10.1002/ijgo.12749.

Koh WJ, Abu-Rustum NR, Bean S, Bradley K, Campos SM, Cho KR, et al. Cervical cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2019; 17(1):64-84. doi: 10.6004/jnccn.2019.0001.

Ramirez PT. ESGO/ESTRO/ESP updated guidelines in cervical cancer. Int J Gynecol Cancer 2023; 33(5):667-8. doi: 10.1136/ijgc-2023-004523.

Holman LL, Levenback CF, Frumovitz M. Sentinel lymph node evaluation in women with cervical cancer. J Minim Invasive Gynecol 2014; 21(4):540-5. doi: 10.1016/j.jmig.2013.12.095.

Altgassen C, Hertel H, Brandstädt A, Köhler C, Durst M, Schneider A. Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 2008; 26(18):2943-51. doi: 10.1200/JCO.2007.13.8933.

Conte M, Panici PB, Guariglia L, Scambia G, Greggi S, Mancuso S. Pelvic lymphocele following radical para-aortic and pelvic lymphadenectomy for cervical carcinoma: incidence rate and percutaneous management. Obstet Gynecol 1990; 76(2):268-71.

Togami S, Kubo R, Kawamura T, Yanazume S, Kamio M, Kobayashi H. Comparison of lymphatic complications between sentinel node navigation surgery and pelvic lymphadenectomy in patients with cervical cancer. Jpn J Clin Oncol 2020; 50(5):543-7. doi: 10.1093/jjco/hyaa001.

National Comprehensive Cancer Network. NCCN Clinical Practice Guidelines in Oncology. Cervical Cancer, Version 1.2024. Disponible en: https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1426 (Consulta: 12 abril 2023).

Lécuru F, Mathevet P, Querleu D, Leblanc E, Morice P, Daraï E, et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the senticol study. J Clin Oncol 2011; 29(13):1686-91. doi: 10.1200/JCO.2010.32.0432.

Cea García J, de la Riva Pérez PA, Rodríguez Jiménez I, Márquez Maraver F, Polo Velasco A, Jiménez Gallardo J, et al. Biopsia selectiva del ganglio centinela en cáncer de cérvix: experiencia en fase de validación. Rev Esp Med Nucl Imagen Mol 2018; 37(6):359-65. doi: 10.1016/j.remn.2018.04.003.

Zhang X, Bao B, Wang S, Yi M, Jiang L, Fang X. Sentinel lymph node biopsy in early stage cervical cancer: a meta‐analysis. Cancer Med 2021; 10(8):2590-600. doi: 10.1002/cam4.3645.

O’Byle JD, Coleman RL, Bernstein SG, Lifshitz S, Muller CY, Miller DS. Intraoperative lymphatic mapping in cervix cancer patients undergoing radical hysterectomy: a pilot study. Gynecol Oncol 2000; 79(2):238-43. doi: 10.1006/gyno.2000.5930.

Khoury-Collado F, Glaser GE, Zivanovic O, Sonoda Y, Levine DA, Chi DS, et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? Gynecol Oncol 2009; 115(3):453-5. doi: 10.1016/j.ygyno.2009.08.026.

Cabanas RM. An approach for the treatment of penile carcinoma. Cancer 1977; 39(2):456-66. doi: 10.1002/1097-0142(197702)39:2<456::aid-cncr2820390214>3.0.co;2-i.

Morales PE, Navarro BC, Monsalve LE. Historia del ganglio centinela. RFM 2007; 30(1):100-2. Disponible en: http://ve.scielo.org/scielo.php?script=sci_arttext&pid=S0798-04692007000100016&lng=es (Consulta: 3 setiembre 2023).

Arribeltz G, Ben M, Dabezies L, de Freitas M de L, Regules E, Caserta B, et al. Investigación del nodo centinela en cáncer de cuello uterino. Gran premio nacional de medicina, Uruguay. Montevideo, 2002.

Salvo G, Ramirez PT, Levenback CF, Munsell MF, Euscher ED, Soliman PT, et al. Sensitivity and negative predictive value for sentinel lymph node biopsy in women with early-stage cervical cancer. Gynecol Oncol 2017; 145(1):96-101. doi: 10.1016/j.ygyno.2017.02.005.

Lennox GK, Covens A. Can sentinel lymph node biopsy replace pelvic lymphadenectomy for early cervical cancer? Gynecol Oncol 2017; 144(1):16-20. doi: 10.1016/j.ygyno.2016.08.33.

Favre G, Guani B, Balaya V, Magaud L, Lecuru F, Mathevet P. Sentinel lymph-node biopsy in early-stage cervical cancer: the 4-year follow-up results of the senticol 2 trial. Front Oncol 2021; 17:10:621518. doi: 10.3389/fonc.2020.621518.

Zanagnolo V, Zahl Eriksson AG, Hudson E, Ferron G, Plante M. SENTICOL III: an international validation study of sentinel node biopsy in early cervical cancer. A GINECO, ENGOT, GCIG and multicenter study. Int J Gynecol Cancer 2019; 29(4):829-34. doi: 10.1136/ijgc-2019-000332.

Ben S, Greif D, Nozar MF, Arribeltz G, Caserta B. Validación de la técnica de Ganglio Centinela en cáncer de vulva en el Hospital de la Mujer. Arch Ginecol Obstret 2022; 60(2): 93-150. doi: 10.54638/60.2.1.

Published

2024-06-07

How to Cite

1.
Ben S, Nozar MF, Greif D, Tarigo J, Tolosa V, Martínez N, et al. Validation of the sentinel lymph node technique in cervical cancer at the Women’s Hospital. Rev. Méd. Urug. [Internet]. 2024 Jun. 7 [cited 2024 Sep. 7];40(2):e204. Available from: https://revista.rmu.org.uy/index.php/rmu/article/view/1086

Most read articles by the same author(s)

1 2 > >>